Preclinical Examination

Digital Tools Accelerating Drug Delivery Development

Yuvraj — Mon, 09 Feb 2026 09:58:24 +0000

Exploration of how computational modeling, high-throughput screening, and digital twins are revolutionizing the pharmaceutical R&D process to optimize formulation efficiency.

The post Digital Tools Accelerating Drug Delivery Development first appeared on World Pharma Today.

Artificial Intelligence in Drug Formulation Development

Yuvraj — Mon, 09 Feb 2026 08:58:13 +0000

Investigation into the role of machine learning and predictive modeling in streamlining the optimization of pharmaceutical recipes and reducing the time-to-market for new therapies.

The post Artificial Intelligence in Drug Formulation Development first appeared on World Pharma Today.

Nanotechnology Applications in Drug Delivery Development

Yuvraj — Fri, 06 Feb 2026 10:30:02 +0000

Investigation into the role of nanoscale carriers in enhancing therapeutic precision, overcoming biological barriers, and enabling the delivery of sensitive genetic materials.

The post Nanotechnology Applications in Drug Delivery Development first appeared on World Pharma Today.

Amgen Eyeing Preclinical Blood Cancer Program to Its Skills

Yuvraj — Sat, 10 Jan 2026 08:57:24 +0000

Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program of U.K. biotech into its organization. The California pharma has gone ahead and stitched together a deal of almost $840 million for Dark Blue Therapeutics, which is a private biotech based out of Oxford. The aim of the biotech is to come […]

The post Amgen Eyeing Preclinical Blood Cancer Program to Its Skills first appeared on World Pharma Today.

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

Yuvraj — Mon, 17 Nov 2025 08:11:53 +0000

Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess drug efficacy rapidly and cost effectively. Dr. Robert Bissonnette, Executive Chairman and Founder of Indero, who initiated […]

The post Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression first appeared on World Pharma Today.